Results 41 to 50 of about 10,402 (207)

Combination of pegylated liposomal doxorubicin and docetaxel as neoadjuvant therapy for breast cancer with axillary lymph node metastasis

open access: yesJournal of International Medical Research, 2020
Objective To evaluate the efficacy and safety of the combination of pegylated liposomal doxorubicin and docetaxel as neoadjuvant therapy for breast cancer (BC) in patients with axillary lymph node metastasis. Methods In this single-arm study, 91 patients
Li Wang   +6 more
doaj   +1 more source

Pegylated Liposomal Doxorubicin in the Treatment of Mycosis Fungoides

open access: yesActa Dermato-Venereologica, 2006
Sir, Mycosis fungoides (MF) is the most common cutaneous T-cell lymphoma. It typically evolves from the early patch and plaque stage to the cutaneous nodular or tumour stage and sometimes visceral involvement is seen in the later stage. MF is also present in an erythrodermic variant accompanied by lymphadenopathy and peripheral blood involvement, known
Lybaek, D   +1 more
openaire   +4 more sources

Temozolomid und pegyliertes liposomales Doxorubicin in Kombination mit Strahlentherapie in der Ersttherapie von Patienten mit Glioblastom WHO Grad IV – eine Phase I/II – Studie (RNOP – 09)

open access: yes, 2011
Hintergrund: Die EORTC26981/NCIC-CE.3-Studie hatte 2005 zur Etablierung eines neuen Standard-Therapieregimes für das Glioblastom geführt. Obwohl sich Temozolomid hierbei als wirksames Agens gezeigt hatte, bleibt die Prognose für diese Entität sehr ...
Schmid, Christina
core   +1 more source

The comparison of biodistribution of glutathione PEGylated nanoliposomal doxorubicin formulations prepared by pre‐insertion and post‐insertion methods for brain delivery in normal mice

open access: yesIET Nanobiotechnology, 2023
Several obstacles limit the efficacy of brain tumour treatment, most notably the blood‐brain barrier (BBB), which prevents the brain uptake of the majority of accessible medicines due to tight junctions. The presence of glutathione (GSH) receptors on the
Amin Mehrabian   +8 more
doaj   +1 more source

A comparison between liposomal and nonliposomal formulations of doxorubicin in the treatment of cancer: An updated review

open access: yesArchives of Pharmacy Practice, 2016
Cancer remains a major cause of hospitalization and death every year. From time to time, new formulations of anticancer drugs are available in the market and draw the concern of healthcare professionals in terms of the superiority, toxicology, and cost ...
Yik Hoe Ngan, Manish Gupta
doaj   +1 more source

Pegylated liposomal doxorubicin: appraisal of its current role in the management of epithelial ovarian cancer

open access: yes, 2011
Maurie MarkmanCancer Treatment Centers of America, Eastern Regional Medical Center, Philadelphia, PA, USAAbstract: Pegylated liposomal doxorubicin (PLD) has become a major component in the routine management of epithelial ovarian cancer.
Markman M, Maurie Markman
core   +1 more source

Palmar-Plantar Erythrodysesthesia Associated with Chemotherapy and Its Treatment

open access: yesCase Reports in Oncology, 2011
Palmar-plantar erythrodysesthesia (PPE), also called hand-foot syndrome, is a relatively common dermatologic toxic reaction associated with cytotoxic chemotherapy that can limit the use of such drugs.
Katherina Podlekareva Farr, Akmal Safwat
doaj   +1 more source

Conventional treatments and non-PEGylated liposome encapsulated doxorubicin for visceral leishmaniasis: A scoping review

open access: yesAsian Pacific Journal of Tropical Medicine, 2022
Visceral leishmaniasis (VL), also known as Kala-azar, is caused by Leishmania (L.) donovani complex, which includes L. donovani and L. infantum and is associated with a high death rate as compared to the cutaneous and subcutaneous form.
Soumya Ranjan Satapathy   +1 more
doaj   +1 more source

Therapeutic Applications of Stimuli‐Based Release and Engineering of Extracellular Vesicles

open access: yesAdvanced NanoBiomed Research, EarlyView.
This review summarizes the effects of endogenous and exogenous stimuli, their effects on the natural release of extracellular vesicles, as well as their uptake and release. It also gives an overview of stimuli‐responsive EVs and their therapeutic applications. Extracellular vesicles (EVs), nano‐ to microsized lipid bilayer membrane‐bound particles, are
Gloria Kemunto, Kristen Dellinger
wiley   +1 more source

Pegylated liposomal doxorubicin for multiple myeloma

open access: yesCochrane Database of Systematic Reviews, 2011
Reason for withdrawal from publication The completion of the last task is overdue for more than one year. New authors are being sought to take over this protocol.
Zhiyong Zeng   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy